You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Lobular Carcinoma

Showing 1 - 25 of 7,866
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pure Florid and Pleomorphic Lobular Carcinoma in Situ of Breast:

Recruiting
  • Pleomorphic Lobular Breast Carcinoma in Situ
  • Breast Florid Lobular Carcinoma in Situ
  • Surgical wide local excision
  • +4 more
  • Padova, Italy
    Istituto Oncologico Veneto IRCCS
Nov 14, 2023

Carcinoma, Lobular Trial ([18F]fluoroestradiol (FES))

Not yet recruiting
  • Carcinoma, Lobular
  • [18F]fluoroestradiol (FES)
  • (no location specified)
Jul 18, 2023

Atypical Hyperplasia, Lobular Carcinoma in Situ Trial in Rochester (Tamoxifen, Topical 4-OHT( 4-hydroxytamoxifen)gel 2 mg/each

Recruiting
  • Atypical Hyperplasia
  • Lobular Carcinoma in Situ
  • Evanston, Illinois
  • +1 more
Jan 20, 2023

Invasive Lobular Breast Carcinoma Trial in Salt Lake City ([18F]Fluoroestradiol (FES) PET/CT)

Recruiting
  • Invasive Lobular Breast Carcinoma
  • [18F]Fluoroestradiol (FES) PET/CT
  • Salt Lake City, Utah
    Huntsman Cancer Institute
Jun 14, 2022

Anatomic Stage I Breast Cancer, Anatomic Stage II Breast Cancer, Anatomic Stage III Breast Cancer Trial in United States

Not yet recruiting
  • Anatomic Stage I Breast Cancer
  • +3 more
  • Endocrine Therapy
  • +7 more
  • Atlanta, Georgia
  • +4 more
Jun 15, 2023

Standard Breast Cancer Risk Assessment for African American and

Not yet recruiting
  • Breast Atypical Ductal Hyperplasia
  • +3 more
  • Biospecimen Collection
  • +2 more
  • Jacksonville, Florida
    Mayo Clinic in Florida
Feb 22, 2023

Metastatic Breast Cancer, Lobular Breast Carcinoma Trial in San Francisco (Blood Specimen)

Not yet recruiting
  • Metastatic Breast Cancer
  • Lobular Breast Carcinoma
  • Blood Specimen
  • San Francisco, California
    University of California, San Francisco
Jul 19, 2023

Lobular Breast Carcinoma Trial in Monaco (68Ga-FAPI-46 PET scan)

Not yet recruiting
  • Lobular Breast Carcinoma
  • 68Ga-FAPI-46 PET scan
  • Monaco, Monaco
    Centre Hospitalier Princesse Grace
Jun 27, 2023

Breast Atypical Ductal Hyperplasia, Breast Atypical Lobular Hyperplasia, Breast Ductal Carcinoma In Situ Trial in Houston

Completed
Has Results
  • Breast Atypical Ductal Hyperplasia
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 13, 2022

Invasive Lobular Breast Carcinoma, ER+ Breast Cancer, HER2-negative Breast Cancer Trial in Belgium, France (Entrectinib,

Recruiting
  • Invasive Lobular Breast Carcinoma
  • +2 more
  • Brussels, Belgium
  • +9 more
May 4, 2022

BRCA Mutation, PALB2 Gene Mutation, Ductal Carcinoma in Situ Trial in Italy (drug, other, behavioral)

Not yet recruiting
  • BRCA Mutation
  • +3 more
  • Tamoxifen 10 Mg Tablet
  • +2 more
  • Genoa, Italy
  • +3 more
Sep 11, 2023

Breast Atypical Hyperplasia, Breast Carcinoma, Breast Ductal Carcinoma In Situ Trial in United States (Acolbifene Hydrochloride,

Not yet recruiting
  • Breast Atypical Hyperplasia
  • +3 more
  • Acolbifene Hydrochloride
  • +4 more
  • Duarte, California
  • +3 more
Jul 11, 2023

Breast Cancer Female, Lobular Breast Carcinoma, PET/MRI Trial (drug, procedure, genetic)

Not yet recruiting
  • Breast Cancer Female
  • +4 more
  • (no location specified)
Aug 8, 2023

Metastatic Cancer, Breast Cancer, Lobular Breast Carcinoma Trial in Madison (18F-fluorofuranylnorprogesterone, Liquid Biopsy,

Recruiting
  • Metastatic Cancer
  • +2 more
  • Madison, Wisconsin
    UW Carbone Cancer Center
Oct 10, 2023

Searching for Novel Germline Mutations in Lobular Breast Cancer

Recruiting
  • Lobular Breast Carcinoma
  • +3 more
  • Illumina panel
  • Milan, Italy
    European Institute of Oncology
Sep 12, 2022

Anatomic Stage IV Breast Cancer AJCC v8, Invasive Breast Lobular Carcinoma, Metastatic Breast Lobular Carcinoma Trial in Atlanta

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +3 more
  • Computed Tomography
  • +3 more
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Aug 9, 2022

Molecular Genetic Basis of Invasive Breast Cancer Risk

Completed
  • Breast Cancer
  • +2 more
  • Tissue specimen
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jun 30, 2021

Breast Cancer Trial in United States (Letrozole, Tamoxifen, Palbociclib)

Active, not recruiting
  • Breast Cancer
  • Stamford, Connecticut
  • +10 more
Jul 15, 2022

Invasive Breast Cancer (Stage I-III), Ductal Carcinoma in Situ, Lobular Carcinoma in Situ Trial in Boston (Naltrexone, Sugar

Terminated
Has Results
  • Invasive Breast Cancer (Stage I-III)
  • +4 more
  • Boston, Massachusetts
  • +1 more
Nov 12, 2021

CDH1 Germline Mutations in Lobular Breast Cancer

Active, not recruiting
  • Lobular Breast Carcinoma
  • CDH1 Gene Inactivation
    • Milan, Italy
      European Institute of Oncology
    Jan 11, 2022

    Cancer Risk, Cancer Predisposition Syndrome, Hereditary Cancer Prediction Trial in Boston (Samples)

    Not yet recruiting
    • Cancer Risk
    • +30 more
    • Samples
    • Boston, Massachusetts
      Dana Farber Cancer Institute
    Jul 14, 2022

    Impact of Dietary Inflammatory Potential on Breast Cancer Risk

    Not yet recruiting
    • Breast Atypical Ductal Hyperplasia
    • +4 more
    • Follow-Up
    • +2 more
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Dec 16, 2021

    Breast Cancer, Node-positive Breast Cancer, Breast Adenocarcinoma Trial in Richmond, South Hill (External Beam Radiation

    Active, not recruiting
    • Breast Cancer
    • +4 more
    • External Beam Radiation Therapy
    • +2 more
    • Richmond, Virginia
    • +1 more
    Dec 16, 2022

    Molecular Analysis of the Sloane Project

    Enrolling by invitation
    • DCIS
    • +3 more
      • London, United Kingdom
        King's College London
      May 11, 2023

      Breast Carcinoma, Breast Ductal Carcinoma In Situ, Breast Lobular Carcinoma In Situ Trial in Columbus (EMBr Wave, Questionnaire

      Recruiting
      • Breast Carcinoma
      • +3 more
      • EMBr Wave
      • Questionnaire Administration
      • Columbus, Ohio
        Ohio State University Comprehensive Cancer Center
      Oct 20, 2021